Watch Amarex’s Keynote Presentation at the 2019 Digital Medicine Summit
Germantown, MD, USA (August 21, 2019) – On May 14, 2019, Amarex’s President & CEO, Dr. Kazem Kazempour, keynoted at the 2019 Digital Medicine Summit/Matching Forum in Taipei, Taiwan.
The full presentation, titled “US FDA Perspective on the Latest Challenges and Opportunities to Regulate AI/ML-based Health Products”, is available at https://www.youtube.com/watch?v=RFMit3whXTc&list=PLh2IsYBD8fNRRpi7EPwoRWapamsWMnVV9&index=3&t=8s.
About Amarex Clinical Research
Amarex is a global, full service Contract Research Organization (CRO), whose leadership team has significant expertise conducting biomedical research, and whose combined experience includes the design and conduct of several hundred clinical research projects in many therapeutic indications. Amarex provides comprehensive services in Project Management (Phase I-IV, BE/BA, PK/PD), Regulatory Affairs (FDA Applications and meetings, Applications to International Health Authorities, GxP Compliance Audits), Clinical Operations, Adaptive Study Designs, Statistical Analysis, Data Management, Medical Monitoring, Safety and Pharmacovigilance, and General Consulting. Amarex can take your product through the entire approval process, from creating the regulatory approval strategy, to conducting trials, to writing the marketing approval application. Join our growing list of clients with approved products. Amarex provides high quality and cost efficient services. For more information visit www.amarexcro.com.
Book a meeting or send us a message to talk to one of our experts.